卫生专家警告美国对药物的关税可能会增加成本和破坏药品供应。 Health experts warn U.S. tariffs on drugs could raise costs and disrupt medicine supplies.

卫生专家和工业团体对拟议的美国进口药品关税提出警告,指出供应链可能受到干扰,基本药品的成本增加。 Health experts and industry groups warn against proposed U.S. tariffs on imported pharmaceuticals, citing potential disruptions to supply chains and increased costs for essential medicines. 欧洲联盟、加拿大和生物技术公司认为,这种关税可能危害病人和紧张的保健系统。 The European Union, Canada, and biotech companies argue that such tariffs could harm patients and strain healthcare systems. 这些警告是在政策制定者考虑新的贸易措施时发出的。 These warnings come as policymakers consider new trade measures.